The rising incidence and persistent thrombosis in multiple cancers including those that are
immunosuppressive highlight the need for understanding the tumor coagulome system and …

Atherosclerosis is a chronic multifactorial disease of the arterial wall characterized by
inflammation, oxidative stress, and immune system activation. Evidence exists on a …

Cancer immunotherapy using cancer vaccines has shown great potential in the prevention
and treatment of cancer. Here, we report an implantable autologous blood clot scaffold for …

Red blood cells (RBCs) have been shown to affect immune function and can induce
inflammatory responses after transfusion. The transfusion of washed RBCs can significantly …

Effective chimeric antigen receptor (CAR)-T cell therapy is dependent on optimal cell culture
methods conducive to the activation and expansion of T cells ex vivo, as well as infection …

With the exception of mammals, vertebrate erythrocytes are nucleated. Nevertheless, these
cells are usually considered as mere carriers of hemoglobin. In this work, however, we …

Lead (Pb) toxicity damages blood cells and disturbs the immune micro-environment. When
Pb enters the circulatory system,> 95% of Pb accumulates in erythrocytes. We therefore …

Studies carried out during the last few decades have consistently shown that cell surface
MHC class I (MHC-I) molecules are endowed with functions unrelated with antigen …

Cytokines, lymphocytes, platelets and several biomolecules have long been implicated in
the pathology of rheumatoid arthritis (RA), and the influences of antibody production and …

For many years red blood cells have been described as inert bystanders rather than
participants in intercellular signalling, immune function, and inflammatory processes …